Ziphius Vaccines
Ghent, Belgium· Est. 2020
To uncover the potential of self-amplifying RNA across a broad spectrum of applications, from addressing infectious diseases to treating rare diseases and advancing next-generation oncology therapies.
Private Company
Total funding raised: $40M
About
To uncover the potential of self-amplifying RNA across a broad spectrum of applications, from addressing infectious diseases to treating rare diseases and advancing next-generation oncology therapies.
RNA & Gene TherapyVaccines
Funding History
2Total raised:$40M
Series A$30MSep 15, 2022
Seed$10MJun 15, 2021